Two recently approved agents offer significant activity against these hard-to-treat conditions.
LYNN NGUYEN, PHARMD
Advertisement
Articles by LYNN NGUYEN, PHARMD
Advertisement
Latest Updated Articles
- Multidrug-Resistant Pseudomonas aeruginosa Infections: Hard to Treat, But Hope on the Horizon?
Published: February 19th 2018 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Developing a COVID-19 Vaccine Alternative
2
Generic Lenacapavir Could Cost as Little as $25 Per Person Annually
3
Building Trust Through Vaccine Education and Science Communication
4
Real-World Data Reinforce Effectiveness and Safety of Fecal Microbiota Therapy for Preventing Recurrent C difficile
5
